U.S. Residents Novartis Oncology
4 Rare Diseases Go to Novartis Oncology
     

Juvenile Myelomonocytic Leukemia

Diagnosis
Patients with JMML may present with:
  • Constitutional symptoms (eg, malaise, pallor, and fever) or evidence of an infection
  • Symptoms of bronchitis or tonsillitis (in approximately 50% of cases)
  • Bleeding diathesis
  • Maculopapular skin rashes (in 40%-50% of cases)
  • Lymphadenopathy (in approximately 75% of cases)
  • Hepatosplenomegaly (in most cases)
A definitive diagnosis of JMML requires the following:

Major criteria (all 3 required)
  • No Philadelphia chromosome or Bcr-Abl fusion gene
  • Peripheral blood monocytosis >1 x 109/L
  • <20% blasts (including promonocytes) in the blood and bone marrow
Minor criteria (2 or more required)
  • Fetal hemoglobin (Hb F) increased for age
  • Immature granulocytes in the peripheral blood
  • White blood cell count >1 x 109/L
  • Clonal chromosomal abnormality (eg, monosomy 7)
  • Granulocyte-macrophage colony-stimulating factor (GM-CSF) hypersensitivity of myeloid progenitors in vitro
Reference:
    National Cancer Institute. Myelodysplastic/Myeloproliferative Diseases (PDQ®): Treatment. Health Professional Version. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/mds-mpd/healthprofessional/allpages. Accessed April 24, 2006.
  Print This Page

Clinical trials

Rare Like Me

Disclaimer: This is an international website dedicated to rare diseases, and intended for healthcare professionals outside the US. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.
About Rare Diseases  |  DFSP  |  HES  |  Mast Cell Disease  |  Myelodysplastic / Myeloproliferative Diseases  |  Resources
Contact    |    Sitemap    |    Privacy
Use of this website is subject to our Terms of Use
©2009 Novartis AG